Egbaria Kamel 4
4 · HI TECH PHARMACAL CO INC · Filed Apr 29, 2011
Insider Transaction Report
Form 4
Egbaria Kamel
Chief Scientific Officer, EVP
Transactions
- Award
Stock Option (Right to Buy)
2011-04-26+40,000→ 40,000 totalExercise: $27.17From: 2012-04-26Exp: 2021-04-26→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
- [F2]The option becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
- [F3]The filer is also the holder of an option to acquire 40,000 shares of Hi-Tech Pharmacal Co., Inc. common stock, which option was granted in 2010.